• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT DIAGNOSTICS SCARBOROUGH, INC. BINAX NOW COVID-19 AG CARD; LATERAL FLOW IMMUNOASSAY IVD OF COVID-19

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT DIAGNOSTICS SCARBOROUGH, INC. BINAX NOW COVID-19 AG CARD; LATERAL FLOW IMMUNOASSAY IVD OF COVID-19 Back to Search Results
Catalog Number 195160
Device Problem False Negative Result (1225)
Patient Problem Epistaxis (4458)
Event Type  Injury  
Manufacturer Narrative
The investigation is still in progress.A supplemental report will be provided after completion.
 
Event Description
The consumer reported that on (b)(6) 2021, after taking a nasal sample from their son to administer the binaxnow¿ covid-19 antigen self test blood appeared.The consumer reported that the bleeding was most likely caused by the swab being inserted a bit too far.The consumer reported that the swab was red.The consumer then inquired if the control line was meant to stay blue because the user's had yet to change.Technical services informed the user that before testing she would need to make sure a blue control line is always present and then after testing the blue control line is meant to change to pink after the 15 minutes.Also, that the results should only be read between the instructed 15-30 minutes; not before or after.In this case, technical service suggested that the user not to take the results into consideration and a second kit would need to be purchased so her son could later on have the two test cards required.Technical services informed the consumer that once her son was treated for his nose bleed and he felt better he could then try to retest again.The customer agreed to take her son to his doctor to treat his nose bleed.No additional information, including treatment and outcome, was provided.
 
Manufacturer Narrative
Investigation: testing was performed at abbott diagnostics scarborough, inc.On retained kit lot 1032793 with internal positive quality control samples and negative quality control swabs.All test results were valid and performed as expected.Additionally, the manufacturing records and quality control release testing was reviewed for test kit part number 190-000 / lot 1032793 and test base part number 190-430 / lot 1032793.The lot met the required release specifications.A review of the complaints reported as false positive patient results (confirmed and unconfirmed, conflicting results) related to kit lot 1032793 showed that the complaint rate is (b)(4).Abbott diagnostics scarborough was unable to determine the exact root cause of the reported issue however a possible assignable root cause is patient sample interference.
 
Manufacturer Narrative
A product deficiency was not reported or identified.Based on the above summary, the investigation is deemed complete.The product will continue to be monitored and tracked.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BINAX NOW COVID-19 AG CARD
Type of Device
LATERAL FLOW IMMUNOASSAY IVD OF COVID-19
Manufacturer (Section D)
ABBOTT DIAGNOSTICS SCARBOROUGH, INC.
10 southgate road
scarborough,
ME 04074
Manufacturer Contact
erina marshall
10 southgate road
scarborough, ME 04074
MDR Report Key12322096
MDR Text Key266629600
Report Number1221359-2021-02267
Device Sequence Number1
Product Code QKP
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
EUA210264
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Consumer
Reporter Occupation Other
Type of Report Initial,Followup,Followup
Report Date 05/12/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue Number195160
Device Lot Number153354
Is the Reporter a Health Professional? No
Initial Date Manufacturer Received 07/21/2021
Initial Date FDA Received08/13/2021
Supplement Dates Manufacturer Received10/28/2021
04/20/2022
Supplement Dates FDA Received11/27/2021
05/12/2022
Was Device Evaluated by Manufacturer? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Reuse
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age15 YR
Patient SexMale
-
-